We are committed to developing and commercializing innovative pharmaceutical products to meet the medical needs of patients with serious and life-threatening conditions. Basilea is located in …

巴塞利亚药业公司研发的治疗重度慢性 手部湿疹 的药物 Alitretinoin (商品名Toctino)是世界上唯一能在所有常规甾体类治疗药物失效后依旧能够发挥治愈效用的药物。 该药物已经在全世界19 …

Anti-infectives, specifically antifungals and antibiotics, is the key focus of Basilea’s strategy. We have successfully brought two anti-infective drugs to the market: the antifungal Cresemba …

2020年11月28日 · isavuconazole是一种静脉和口服唑类抗真菌药物，用于治疗毛霉菌病和曲霉菌病。 2020年11月28日讯 / 生物谷 BIOON/ --巴塞利亚药业有限公司 (Basilea Pharmaceutica …

Continuous infusion with portable pumps is an established mode of drug administration used for the treatment of certain cancers. Prof. Achim Kaufhold, Basilea's Chief Medical Officer, …

Breaking news and analysis of the global biotechnology, pharmaceutical, medical device and medical technology sectors. In-depth coverage of innovation, business, financing, regulation, …

Basilea Pharmaceutica is a biopharmaceutical company based in Allschwil near Basel, Switzerland. [4] Basilea was spun off from F. Hoffmann-La Roche in 2000 and has been listed …

About Basilea Basilea is a commercial-stage biopharmaceutical company founded in 2000 and headquartered in Switzerland. We are committed to discovering, developing and …

Basilea is focused on developing and commercialising therapies for the treatment of severe fungal and bacterial infections (Exhibit 1). Its two marketed products are Cresemba (or …

We have successfully launched two hospital brands, Cresemba for the treatment of invasive fungal infections and Zevtera for the treatment of bacterial infections. In addition, we have …